SK286757B6 - 17-Metylénsteroidy, spôsob ich prípravy, farmaceutické kompozície, ktoré ich obsahujú, a ich použitie - Google Patents
17-Metylénsteroidy, spôsob ich prípravy, farmaceutické kompozície, ktoré ich obsahujú, a ich použitie Download PDFInfo
- Publication number
- SK286757B6 SK286757B6 SK244-2003A SK2442003A SK286757B6 SK 286757 B6 SK286757 B6 SK 286757B6 SK 2442003 A SK2442003 A SK 2442003A SK 286757 B6 SK286757 B6 SK 286757B6
- Authority
- SK
- Slovakia
- Prior art keywords
- chloro
- estr
- pseudohalogen
- formula
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10043846A DE10043846A1 (de) | 2000-09-04 | 2000-09-04 | 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen |
PCT/EP2001/009943 WO2002019971A1 (de) | 2000-09-04 | 2001-08-29 | 4-halogenierte 17-methylensteroide, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen |
Publications (2)
Publication Number | Publication Date |
---|---|
SK2442003A3 SK2442003A3 (en) | 2003-08-05 |
SK286757B6 true SK286757B6 (sk) | 2009-05-07 |
Family
ID=7655148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK244-2003A SK286757B6 (sk) | 2000-09-04 | 2001-08-29 | 17-Metylénsteroidy, spôsob ich prípravy, farmaceutické kompozície, ktoré ich obsahujú, a ich použitie |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1423407B1 (et) |
JP (1) | JP2004513084A (et) |
KR (1) | KR100530816B1 (et) |
CN (1) | CN1262560C (et) |
AT (1) | ATE319733T1 (et) |
AU (2) | AU2002210470B2 (et) |
BG (1) | BG107594A (et) |
BR (1) | BR0113618A (et) |
CA (1) | CA2421302C (et) |
DE (2) | DE10043846A1 (et) |
DK (1) | DK1423407T3 (et) |
EA (1) | EA006387B1 (et) |
EE (1) | EE05186B1 (et) |
ES (1) | ES2260294T3 (et) |
HK (1) | HK1060135A1 (et) |
HR (1) | HRP20030256A2 (et) |
HU (1) | HUP0300936A3 (et) |
IL (2) | IL154666A0 (et) |
ME (1) | MEP14408A (et) |
MX (1) | MXPA03001912A (et) |
NO (1) | NO325012B1 (et) |
NZ (1) | NZ524485A (et) |
PL (1) | PL360669A1 (et) |
PT (1) | PT1423407E (et) |
RS (1) | RS50305B (et) |
SK (1) | SK286757B6 (et) |
UA (1) | UA74592C2 (et) |
WO (1) | WO2002019971A1 (et) |
ZA (1) | ZA200301715B (et) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10141984A1 (de) * | 2001-08-28 | 2003-03-20 | Jenapharm Gmbh | Neue 17-Methylen-4-azasteroide |
US7199115B2 (en) | 2004-04-19 | 2007-04-03 | Schering Ag | 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them |
AT12800U1 (de) * | 2007-11-05 | 2012-11-15 | Bayer Schering Pharma Ag | Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2611773A (en) * | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
US3146239A (en) * | 1957-09-23 | 1964-08-25 | Syntex Corp | 4-halo-19-nor-progesterone |
US3232960A (en) * | 1959-10-08 | 1966-02-01 | Upjohn Co | 3-keto-4-fluoro- and 3-keto-4,4-difluorosteroids and process |
US3661940A (en) * | 1970-04-13 | 1972-05-09 | Sandoz Ag | Derivatives of 21-methyl-19-norpregnanes |
US4389345A (en) * | 1981-10-09 | 1983-06-21 | G.D. Searle & Co. | 3-Oxoestra-17-acetonitrile and unsaturated analogs |
US5994334A (en) * | 1997-02-05 | 1999-11-30 | University Of Maryland | Androgen synthesis inhibitors |
WO2002000681A1 (en) * | 2000-06-27 | 2002-01-03 | Aventis Pharma S.A. | 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase |
-
2000
- 2000-09-04 DE DE10043846A patent/DE10043846A1/de not_active Ceased
-
2001
- 2001-08-29 ME MEP-144/08A patent/MEP14408A/xx unknown
- 2001-08-29 AU AU2002210470A patent/AU2002210470B2/en not_active Ceased
- 2001-08-29 AU AU1047002A patent/AU1047002A/xx active Pending
- 2001-08-29 DK DK01978315T patent/DK1423407T3/da active
- 2001-08-29 EA EA200300322A patent/EA006387B1/ru not_active IP Right Cessation
- 2001-08-29 EP EP01978315A patent/EP1423407B1/de not_active Expired - Lifetime
- 2001-08-29 AT AT01978315T patent/ATE319733T1/de not_active IP Right Cessation
- 2001-08-29 HU HU0300936A patent/HUP0300936A3/hu unknown
- 2001-08-29 BR BR0113618-6A patent/BR0113618A/pt not_active IP Right Cessation
- 2001-08-29 UA UA2003042852A patent/UA74592C2/uk unknown
- 2001-08-29 RS YUP-164/03A patent/RS50305B/sr unknown
- 2001-08-29 PT PT01978315T patent/PT1423407E/pt unknown
- 2001-08-29 IL IL15466601A patent/IL154666A0/xx unknown
- 2001-08-29 SK SK244-2003A patent/SK286757B6/sk not_active IP Right Cessation
- 2001-08-29 DE DE50109175T patent/DE50109175D1/de not_active Expired - Lifetime
- 2001-08-29 ES ES01978315T patent/ES2260294T3/es not_active Expired - Lifetime
- 2001-08-29 EE EEP200300087A patent/EE05186B1/et not_active IP Right Cessation
- 2001-08-29 CA CA002421302A patent/CA2421302C/en not_active Expired - Fee Related
- 2001-08-29 PL PL36066901A patent/PL360669A1/xx unknown
- 2001-08-29 NZ NZ524485A patent/NZ524485A/en unknown
- 2001-08-29 JP JP2002524456A patent/JP2004513084A/ja active Pending
- 2001-08-29 CN CNB018151345A patent/CN1262560C/zh not_active Expired - Fee Related
- 2001-08-29 KR KR10-2003-7003170A patent/KR100530816B1/ko not_active IP Right Cessation
- 2001-08-29 WO PCT/EP2001/009943 patent/WO2002019971A1/de active IP Right Grant
- 2001-08-29 MX MXPA03001912A patent/MXPA03001912A/es active IP Right Grant
-
2003
- 2003-02-27 IL IL154666A patent/IL154666A/en not_active IP Right Cessation
- 2003-02-27 BG BG107594A patent/BG107594A/bg unknown
- 2003-02-28 ZA ZA200301715A patent/ZA200301715B/en unknown
- 2003-03-03 NO NO20030989A patent/NO325012B1/no not_active IP Right Cessation
- 2003-04-04 HR HR20030256A patent/HRP20030256A2/hr not_active Application Discontinuation
-
2004
- 2004-04-27 HK HK04102956A patent/HK1060135A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1272504B1 (de) | 8.beta.-hydrocarbyl-substituierte estratriene als selektiv wirksame estrogene | |
US6855836B2 (en) | 17-Methylene steroids, process for their production and pharmaceutical compositions that contain these compounds | |
EP1169336B1 (en) | Ent-steroids as selectively active estrogens | |
NO329563B1 (no) | 9-alfa-substituerte ostratriener som selektivt aktive ostrogener, farmasoytiske preparater som inneholder forbindelsene, samt anvendelse derav til fremstilling av farmasoytiske midler | |
DE19906159A1 (de) | 16-Hydroxyestratriene als selektiv wirksame Estrogene | |
CA2384184C (en) | 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties | |
EP1226155B1 (de) | 18-nor-steroide als selektiv wirksame estrogene | |
US7199115B2 (en) | 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them | |
SK286757B6 (sk) | 17-Metylénsteroidy, spôsob ich prípravy, farmaceutické kompozície, ktoré ich obsahujú, a ich použitie | |
HUT54707A (en) | Process for producing 14,17-etheno- and -etheno-estratrienes and pharmaceutical compositions containing them | |
EP1737880B1 (de) | 17 alpha-fluor 17 beta-hydroximinomethyl-steroide, ein verfahren zu deren herstellung und diese verbindung enthaltende pharmazeutische zusammensetzungen | |
DE10019167A1 (de) | Substituierte Estratriene als selektiv wirksame Estrogene | |
NZ536882A (en) | 9-Alpha-substituted estratrienes as selectively active estrogens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20100829 |